Company: USPH
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001140361-25-013467
Chunk: 53

Company: U S PHYSICAL THERAPY INC /NV
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 53
---
 1, 2021, $119.34on July 1, 2021, $111.55on October 1, 2021, $114.35on January 1, 2020, $59.00on April 1, 2020, $81.02on July 1, 2020 and $86.88on October 1, 2020. |

| (4) | Includes dividends paid and declared on outstanding and unvested shares as of December 31, 2024, 2023, 2022, 2021 and 2020. Dividends declared per common share were $1.76, $1.72, $1.64, $1.46, and $0.32for the fiscal years ended December 31, 2023, 2022, 2021 and 2020, respectively. |

35

TABLE OF CONTENTS Relationship between Pay and TSR The graph below illustrates the relationship between compensation actually paid to the PEO and other NEOs, the cumulative total stockholder return (“TSR”) on $100 invested in the Company at the close of the market on December 31, 2020, with dividends being reinvested on the date paid through December 31, 2024, and the cumulative TSR of the NYSE Health Care Index. The NYSE Health Care Index TSR is calculated in a similar manner as the Company’s TSR. Relationship between Pay and Net Income The graph below illustrates the relationship between compensation actually paid to the PEO and other NEOs and the Company’s net income. 36 TABLE OF CONTENTS Relationship between Pay and Operating Results The graph below illustrates the relationship between compensation actually paid to the PEO and other NEOs and the Company’s After-tax Operating Results. Relationship between Pay and Adjusted EBITDA The graph below illustrates the relationship between compensation actually paid to the PEO and other NEOs and the Company’s Adjusted EBITDA. 37

TABLE OF CONTENTS

Post Termination/Change-in-Control Benefits The amount of compensation payable to each Named Executive Officer under the agreements is detailed in the tables below – for more information, please see Employment Agreements, Severance and Change in Control Benefits on page 26: Christopher J. Reading Chairman of the Board of Directors and Chief Executive Officer

| Executive Benefits and Payments                 
 Upon Termination(1)                             |     | Voluntary   
 Termination 
 or For      
 Cause       |     |